At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 285 enrolled
Drug / intervention
VVZ-149 Injections +1 moredrug
Likely dose
VVZ-149 Injections 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Laparoscopic Colectomy
In Brief
A Phase 3 clinical trial evaluating VVZ-149 Injections and Placebo for Pain, Postoperative and Acute Pain. Completed, enrolled 285 participants across 5 sites.
Detailed Summary
The purpose of this phase 3 study is to evaluate the efficacy and safety of VVZ-149 Injections for the treatment of postoperative pain following laparoscopic colectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative, Acute Pain
CountriesSouth Korea
Collaborators--
Timeline
Phase 3CompletedFinished
20222023202420252026
Enrollment StartJul 2021
Primary CompletionNov 2022
Study CompletionNov 2022
First PostedMar 2023
TodayJul 2026
First PostedMar 10, 2023
Enrollment StartJul 19, 2021
Primary CompletionNov 3, 2022
Study CompletionNov 22, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.3 years ago
Interventions
VVZ-149 Injectionsdrug
IV infusion of 1000 mg of VVZ-149
Placebodrug
IV infusion of 0 mg of VVZ-149